Esperion Therapeutics, Inc., represented by the ticker symbol ESPR on the NASDAQ, experienced a significant surge in its shares during today’s pre-market trading. The catalyst? The company’s unveiling of new data from CLEAR outcomes at ACC.24, shedding light on the value of NEXLETOL® tablets across diverse populations.
Bolstered by this positive development, Esperion Therapeutics shares soared by 7.1% to reach $3.47 in pre-market trading.
Let’s now delve into the other notable movements in pre-market trading today.
Noteworthy Gainers
- Longeveron Inc., under the ticker LGVN on the NASDAQ, exhibited a remarkable upsurge of 93.2% to hit $4.25 in pre-market trading following an 8% rise on Friday.
- Antelope Enterprise Holdings Limited saw its shares, tagged as AEHL on the NASDAQ, spike by 47% to $2.20 in pre-market trading after a 5% decline on Friday. Remarkably, Antelope Enterprise had announced a preliminary full year 2023 revenue of $70.4 million on April 1.
- DigiAsia Corp. shares, trading under the ticker FAAS on the NASDAQ, surged by 31.6% to $8.46 in pre-market trading, building on a 17% gain from Friday.
- BYND Cannasoft Enterprises Inc., with the ticker BCAN on the NASDAQ, witnessed an impressive rise of 27.2% to $1.31 in pre-market trading.
- Allarity Therapeutics, Inc., represented by the ticker ALLR on the NASDAQ, climbed by 25.6% to $0.2840 in pre-market trading after a slight pullback of over 8% on Friday. Notably, the company had recently announced a 1-for-20 reverse stock split.
- Auddia Inc., trading under the ticker AUUD on the NASDAQ, experienced a surge of 15.4% to $1.65 in pre-market trading, following a minor decline of around 5% on Friday.
- Galmed Pharmaceuticals Ltd. shares, with the ticker symbol GLMD on the NASDAQ, rose by 15% to $0.39 in pre-market trading. Last week, Galmed Pharmaceuticals had filed its annual report on Form 20-F for the fiscal year ended December 31, 2023.
- Destiny Tech100 Inc., traded under the ticker DXYZ on the NASDAQ, mounted a 10.3% climb to $65.36 in pre-market trading, consolidating on a substantial 77% surge on Friday.
- MicroStrategy Incorporated, known by the ticker MSTR on the NASDAQ, exhibited a noteworthy gain of 9.4% to reach $1,573.93 in pre-market trading, coinciding with a rise in Bitcoin prices.
Significant Losers
- 22nd Century Group, Inc., trading under the ticker XXII on the NASDAQ, saw a decline of 22.4% to $2.76 in pre-market trading. The previous day, the company’s shares had soared over 140% after signing a new contract manufacturing agreement for branded conventional cigarette products.
- MediaCo Holding Inc., with the ticker MDIA on the NASDAQ, experienced a drop of 18.8% to $3.15 in pre-market trading. MediaCo Holding had observed a staggering 177% increase in share value on Friday after a 13D amended filing revealed that Standard General L.P. possessed a 95.2% stake in the company as of April 1, 2024.
- Flora Growth Corp., trading under the ticker FLGC on the NASDAQ, faced a decline of 15.1% to $2.02 in pre-market trading. Notably, Flora Growth had recently announced the pricing of its underwritten public offering of 1.7 million common shares, generating aggregate gross proceeds of approximately $3.23 million.
- ZOOZ Power Ltd., with the ticker symbol ZOOZ on the NASDAQ, witnessed a dip of 14.5% to $3.50 in pre-market trading.
- Netcapital Inc., represented by the ticker NCPL on the NASDAQ, experienced a 13.5% decline to $0.1064 in pre-market trading following a 6% decrease on Friday.
- Globavend Holdings Limited, trading under the ticker GVH on the NASDAQ, observed a decline of 11% to $1.46 in pre-market trading after a 57% jump on Friday.
- CCSC Technology International Holdings Limited, with the ticker CCTG on the NASDAQ, faced an 8% drop to $3.11 in pre-market trading after a surge of approximately 28% on Friday.
- BRC Inc., under the ticker BRCC on the NYSE, saw its shares decline by 7.8% to $4.38 in pre-market trading after a 5% surge on Friday.
- Reliance Global Group, Inc., represented by the ticker RELI on the NASDAQ, experienced a 6.8% fall to $0.4523 in pre-market trading. Recall that Reliance Global had recently unveiled its FY23 earnings report.
- Eupraxia Pharmaceuticals Inc., trading under the ticker EPRX on the NASDAQ, faced a 5.1% decline to $2.80 in pre-market trading.
For more insights: RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday
